Author:
Sandweiss A J,McIntosh M I,Moutal A,Davidson-Knapp R,Hu J,Giri A K,Yamamoto T,Hruby V J,Khanna R,Largent-Milnes T M,Vanderah T W
Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,Psychiatry and Mental health,Molecular Biology
Reference46 articles.
1. Schuckit MA. Treatment of opioid-use disorders. N Engl J Med 2016; 375: 357–368.
2. Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain—United States. JAMA 2016; 315: 1624–1645.
3. Sandweiss AJ, Vanderah TW. The pharmacology of neurokinin receptors in addiction: prospects for therapy. Subst Abuse Rehabil 2015; 6: 93–102.
4. Largent-Milnes TM, Yamamoto T, Nair P, Moulton JW, Hruby VJ, Lai J et al. Spinal or systemic TY005, a peptidic opioid agonist/neurokinin 1 antagonist, attenuates pain with reduced tolerance. Br J Pharmacol 2010; 161: 986–1001.
5. Staubli U, Huston JP. Central action of substance P: possible role in reward. Behav Neural Biol 1985; 43: 100–108.
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献